Skip to main content

Advertisement

Table 3 Percentage (%) distributions and odds ratios for receipt of conservative therapy (n = 3,328).

From: Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

Characteristic % Crude 1 OR (95% CI) Adj.2 OR (95% CI)
Age at diagnosis      
   <60 12.13 1.00 (referent) 1.00 (referent)
   60-64 17.96 1.59 (1.15 - 2.20) 1.65 (1.18 - 2.33)
   65-69 20.38 1.85 (1.37 - 2.52) 1.90 (1.38 - 2.63)
   70-74 32.58 3.50 (2.63 - 4.71) 3.35 (2.46 - 4.59)
   75-79 46.71 6.35 (4.70 - 8.67) 6.76 (4.87 - 9.47)
   >= 80 82.49 34.13 (23.00 - 51.68) 27.09 (17.66 - 42.31)
Race/ethnicity      
   Non-Hispanic White 27.59 1.00 (referent) 1.00 (referent)
   Non-Hispanic Black 37.85 1.60 (1.30 - 1.96) 1.65 (1.28 - 2.13)
   Non-Hispanic Other 33.93 1.35 (0.76 - 2.33) 1.28 (0.66 - 2.40)
   Hispanic 35.96 1.47 (0.99 - 2.17) 1.56 (0.98 - 2.45)
   Unknown 36.36 1.50 (0.60 - 3.52) 1.02 (0.31 - 3.02)
Marital status      
   Married 25.16 1.00 (referent) 1.00 (referent)
   Not Married 42.81 2.23 (1.86 - 2.67) 1.72 (1.39 - 2.14)
   Unknown 42.22 2.17 (1.59 - 2.96) 1.70 (1.15 - 2.49)
Insurance      
   Private/other 26.03 1.00 (referent) 1.00 (referent)
   None 30.77 1.26 (0.52 - 2.83) 2.31 (0.89 - 5.52)
   Public 40.18 1.91 (1.58 - 2.31) 1.51 (1.20 - 1.89)
   Unknown 38.98 1.82 (1.39 - 2.37) 1.60 (1.14 - 2.25)
Registry      
   California 31.56 1.00 (referent) 1.00 (referent)
   Colorado 27.50 0.82 (0.63 - 1.08) 1.37 (0.99 - 1.90)
   Illinois 32.38 1.04 (0.80 - 1.35) 0.95 (0.68 - 1.32)
   Louisiana 31.13 0.98 (0.75 - 1.28) 0.59 (0.42 - 0.82)
   New York 26.07 0.77 (0.58 - 1.01) 0.85 (0.60 - 1.20)
   Rhode Island 29.31 0.90 (0.68 - 1.18) 1.12 (0.80 - 1.56)
   South Carolina 27.07 0.81 (0.60 - 1.09) 0.63 (0.43 - 0.91)
Screen-detected      
   Yes 22.60 1.00 (referent) 1.00 (referent)
   No 43.17 2.60 (2.20 - 3.08) 2.32 (1.86 - 2.91)
   Unknown 36.87 2.00 (1.57 - 2.53) 1.47 (1.08 - 1.99)
DRE results      
   Normal 29.42 1.00 (referent) 1.00 (referent)
   Abnormal 24.40 0.77 (0.65 - 0.93) 0.67 (0.54 - 0.84)
   Equivocal/unknown 35.48 1.32 (1.10 - 1.58) 0.91 (0.73 - 1.15)
PSA value      
   0-4 27.59 1.00 (referent) 1.00 (referent)
   >4-10 20.15 0.66 (0.50 - 0.88) 0.69 (0.50 - 0.97)
   >10-20 29.01 1.07 (0.79 - 1.47) 0.80 (0.56 - 1.15)
   >20-50 45.38 2.18 (1.53 - 3.12) 1.41 (0.93 - 2.15)
   50+ 52.25 2.87 (1.83 - 4.53) 1.73 (1.02 - 2.94)
   Unknown 49.89 2.61 (1.91 - 3.60) 1.64 (1.12 - 2.41)
Gleason score      
   2-4 45.17 1.00 (referent) 1.00 (referent)
   5-7 25.05 0.41 (0.32 - 0.51) 0.45 (0.34 - 0.59)
   8-10 34.26 0.63 (0.46 - 0.87) 0.49 (0.33 - 0.72)
   Unknown 48.58 1.15 (0.88 - 1.61) 0.75 (0.50 - 1.13)
Comorbidity score      
   0 26.91 1.00 (referent) 1.00 (referent)
   1 39.00 1.74 (1.41 - 2.14) 1.44 (1.12 - 1.86)
   2+ 54.78 3.29 (2.26 - 4.81) 2.59 (1.67 - 4.03)
  1. 1: OR = odds ratio; CI = confidence interval.
  2. 2: Adjusted for factors shown in the table.